Abstract 2246: Androgen receptor expression in non-small cell lung cancer circulating tumor cells

Jennifer L. Schehr(University of Wisconsin–Madison), Joshua M. Lang(University of Wisconsin–Madison), Zachery D. Schultz(University of Wisconsin–Madison), Anne M. Traynor(University of Wisconsin Carbone Cancer Center), Jamie M. Sperger(University of Wisconsin–Madison), Kara Mattox(University of Wisconsin–Madison), Anwaar Saeed(University of Pittsburgh), Ticiana Leal(University of Wisconsin Carbone Cancer Center)
Cancer Research
July 15, 2016
10.1158/1538-7445.am2016-2246
Cited by 0

Related Papers

Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2019|1.6k
Five-Year Outcomes With Pembrolizumab Versus Chemotherapy for Metastatic Non–Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50%
|Journal of Clinical Oncology|2021|1.1k
NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 2.2021
|Journal of the National Comprehensive Cancer Network|2021|1k
NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 1.2020
|Journal of the National Comprehensive Cancer Network|2019|1k
Updated Overall Survival and PD-L1 Subgroup Analysis of Patients With Extensive-Stage Small-Cell Lung Cancer Treated With Atezolizumab, Carboplatin, and Etoposide (IMpower133)
|Journal of Clinical Oncology|2021|818